Thermostability of IFN-γ and IP-10 release assays for latent infection with Mycobacterium tuberculosis: A TBnet study
- PMID: 27156612
- DOI: 10.1016/j.tube.2015.04.013
Thermostability of IFN-γ and IP-10 release assays for latent infection with Mycobacterium tuberculosis: A TBnet study
Abstract
Introduction: Interferon-γ (IFN-γ) inducible protein 10kD (IP-10) and IFN-γ release assays (IGRAs) are immunodiagnostic tests aiming to identify the presence of specific cellular immune responses, interpreted as markers for latent infection with Mycobacterium tuberculosis. Incubation at higher temperatures could affect IFN-γ and IP-10 responsiveness in order to improve the performance of IP-10 release assays and IGRAs.
Aim: The aim of this study was to assess the robustness of whole blood based IP-10 release assay and IGRAs and the effect of hyper-thermic incubation (39 °C) on the diagnostic accuracy of IP-10 release assay and IGRAs.
Results: We included 65 patients with confirmed pulmonary tuberculosis and 160 healthy controls from 6 European centres collaborating in the TBnet. In patients, IP-10 responses increased 1.07 (IQR 0.90-1.36) fold and IFN-γ responses decreased 0.88 (IQR 0.57-1.02) fold, with 39 °C compared to 37 °C incubation temperature. At 37 °C IGRA sensitivity was 85% and IP-10 sensitivity was 82%, whereas specificity was 97% for both tests (p > 0.8). These minor changes observed as a result of hyper-thermic incubation were not sufficient to impact IGRA and IP-10 release assay test performance.
Conclusion: The performance of IGRA and IP-10 release assays is robust despite variations in the incubation temperature between 37 °C and 39 °C.
Keywords: Hyperthermia; IGRA; IP-10 release assay; Mycobacterium. tuberculosis.
Copyright © 2015 Elsevier Ltd. All rights reserved.
Similar articles
-
Development of a one-step probe based molecular assay for rapid immunodiagnosis of infection with M. tuberculosis using dried blood spots.PLoS One. 2014 Sep 3;9(9):e105628. doi: 10.1371/journal.pone.0105628. eCollection 2014. PLoS One. 2014. PMID: 25184553 Free PMC article.
-
Evaluation of IP-10 in Quantiferon-Plus as biomarker for the diagnosis of latent tuberculosis infection.Tuberculosis (Edinb). 2018 Jul;111:147-153. doi: 10.1016/j.tube.2018.06.005. Epub 2018 Jun 12. Tuberculosis (Edinb). 2018. PMID: 30029901
-
Performance of Interferon-Gamma and IP-10 Release Assays for Diagnosing Latent Tuberculosis Infections in Patients with Concurrent Malaria in Tanzania.Am J Trop Med Hyg. 2016 Apr;94(4):728-35. doi: 10.4269/ajtmh.15-0633. Epub 2016 Feb 1. Am J Trop Med Hyg. 2016. PMID: 26834199 Free PMC article.
-
[Evolution of IGRA researches].Kekkaku. 2008 Sep;83(9):641-52. Kekkaku. 2008. PMID: 18979999 Review. Japanese.
-
Accuracy of interferon-γ-induced protein 10 for diagnosing latent tuberculosis infection: a systematic review and meta-analysis.Clin Microbiol Infect. 2019 Jun;25(6):667-672. doi: 10.1016/j.cmi.2018.12.006. Epub 2018 Dec 14. Clin Microbiol Infect. 2019. PMID: 30553864
Cited by
-
Fever as an important resource for infectious diseases research.Intractable Rare Dis Res. 2016 May;5(2):97-102. doi: 10.5582/irdr.2016.01009. Intractable Rare Dis Res. 2016. PMID: 27195192 Free PMC article. Review.
-
Mycobacterium tuberculosis sigE mutant ST28 used as a vaccine induces protective immunity in the guinea pig model.Tuberculosis (Edinb). 2017 Sep;106:99-105. doi: 10.1016/j.tube.2017.07.009. Epub 2017 Jul 24. Tuberculosis (Edinb). 2017. PMID: 28802412 Free PMC article.
-
Alternative biomarkers of tuberculosis infection in patients with immune-mediated inflammatory diseases.Front Med (Lausanne). 2023 Nov 23;10:1271632. doi: 10.3389/fmed.2023.1271632. eCollection 2023. Front Med (Lausanne). 2023. PMID: 38076244 Free PMC article.
-
Accumulate evidence for IP-10 in diagnosing pulmonary tuberculosis.BMC Infect Dis. 2019 Oct 30;19(1):924. doi: 10.1186/s12879-019-4466-5. BMC Infect Dis. 2019. PMID: 31666025 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources